chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site scar, Vaccination site swelling
Clinical narrative: Hot at injection site; injection site spot wasn't hot or raised or itchy; not as Itchy red spot not as defined a circle as the first one; red,hot,reased and not as itchy red "spot"; Red at injection site; raised 4.5 inch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE SCAR (injection site spot wasn't hot or raised or itchy), VACCINATION SITE PRURITUS (not as Itchy red spot not as defined a circle as the first one), VACCINATION SITE RASH (red,hot,reased and not as itchy red "spot") and VACCINATION SITE ERYTHEMA (Red at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Skin rash (Had genetic skin rashes in past.). Concurrent medical conditions included Sulfonamide allergy and Seasonal allergy (Seasonal allergy (hay fever)). Concomitant products included MULTIVITAMIN [VITAMINS NOS], ACETYLSALICYLIC ACID (ASPIRIN 81) and CALCIUM, COLECALCIFEROL (CALCIUM VITAMIN D) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE SCAR (injection site spot wasn't hot or raised or itchy), VACCINATION SITE PRURITUS (not as Itchy red spot not as defined a circle as the first one), VACCINATION SITE RASH (red,hot,reased and not as itchy red "spot"), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE SWELLING (raised 4.5 inch at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (not as Itchy red spot not as defined a circle as the first one), VACCINATION SITE RASH (red,hot,reased and not as itchy red "spot"), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE SWELLING (raised 4.5 inch at injection site) had resolved and VACCINATION SITE SCAR (injection site spot wasn't hot or raised or itchy) had not resolved.            This case was linked to MOD-2021-012126 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Hot at injection site; injection site spot wasn't hot or raised or itchy; not as Itchy red spot not as defined a circle as the first one; red,hot,reased and not as itchy red "spot"; Red at injection site; raised 4.5 inch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE SCAR (injection site spot wasn't hot or raised or itchy), VACCINATION SITE PRURITUS (not as Itchy red spot not as defined a circle as the first one), VACCINATION SITE RASH (red,hot,reased and not as itchy red "spot") and VACCINATION SITE ERYTHEMA (Red at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Skin rash (Had genetic skin rashes in past.). Concurrent medical conditions included Sulfonamide allergy and Seasonal allergy (Seasonal allergy (hay fever)). Concomitant products included MULTIVITAMIN [VITAMINS NOS], ACETYLSALICYLIC ACID (ASPIRIN 81) and CALCIUM, COLECALCIFEROL (CALCIUM VITAMIN D) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE SCAR (injection site spot wasn't hot or raised or itchy), VACCINATION SITE PRURITUS (not as Itchy red spot not as defined a circle as the first one), VACCINATION SITE RASH (red,hot,reased and not as itchy red "spot"), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE SWELLING (raised 4.5 inch at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (not as Itchy red spot not as defined a circle as the first one), VACCINATION SITE RASH (red,hot,reased and not as itchy red "spot"), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE SWELLING (raised 4.5 inch at injection site) had resolved and VACCINATION SITE SCAR (injection site spot wasn't hot or raised or itchy) had not resolved.            This case was linked to MOD-2021-012126 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: arthritis pain on her right leg from knee down to the foot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRITIS (arthritis pain on her right leg from knee down to the foot) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), INSULIN DEGLUDEC (TRESIBA), INSULIN LISPRO (HUMALOG), CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (COMBIVENT), OXYGEN, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (PROAIR BRONQUIAL), DOCUSATE SODIUM (STOOL SOFTENER) and AMLODIPINE for an unknown indication.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced ARTHRITIS (arthritis pain on her right leg from knee down to the foot). At the time of the report, ARTHRITIS (arthritis pain on her right leg from knee down to the foot) had not resolved. Not Provided          No treatment information provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route)  was not applicable.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Vaccination site pain
Clinical narrative: A lot of arm pain rating 9 or 10 (from scale of 1 to 10) not constant at the injection site; Tenderness in the arm at the injection site after the second vaccine dose; Soreness in the arm at the injection site after the second vaccine dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A lot of arm pain rating 9 or 10 (from scale of 1 to 10) not constant at the injection site), VACCINATION SITE PAIN (Tenderness in the arm at the injection site after the second vaccine dose) and MYALGIA (Soreness in the arm at the injection site after the second vaccine dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 025B21A) for COVID-19 vaccination.    Co-suspect product included non-company product ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    Concomitant products included PARACETAMOL (TYLENOL) and ACETAMINOPHEN for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) (unknown route) at an unspecified dose. On 15-Apr-2021, the patient experienced VACCINATION SITE PAIN (Tenderness in the arm at the injection site after the second vaccine dose) and MYALGIA (Soreness in the arm at the injection site after the second vaccine dose). On 19-Apr-2021, the patient experienced PAIN IN EXTREMITY (A lot of arm pain rating 9 or 10 (from scale of 1 to 10) not constant at the injection site). At the time of the report, PAIN IN EXTREMITY (A lot of arm pain rating 9 or 10 (from scale of 1 to 10) not constant at the injection site), VACCINATION SITE PAIN (Tenderness in the arm at the injection site after the second vaccine dose) and MYALGIA (Soreness in the arm at the injection site after the second vaccine dose) outcome was unknown.            Concomitant medication was not provided Treatment medication includes Cold pack .
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Fatigue, Headache, Injection site bruising
Clinical narrative: Chills; Swollen/tender lymph nodes underarm on the side of the injection site; Bruising at injection site; Cold sweats; Sore arm/body ache; Fatigue; Nausea; Headache; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (Bruising at injection site), COLD SWEAT (Cold sweats), LYMPHADENOPATHY (Swollen/tender lymph nodes underarm on the side of the injection site), MYALGIA (Sore arm/body ache) and FATIGUE (Fatigue) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypothyroidism and Anxiety depression. Concurrent medical conditions included Bee sting and Penicillin allergy. Concomitant products included BUSPIRONE for Anxiety, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for Depression, LEVOTHYROXINE for Hypothyroidism, MELATONIN for Sleep problem.   On 21-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced MYALGIA (Sore arm/body ache), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PAIN (pain at injection site). On 23-Apr-2021 at 5:00 PM, the patient experienced COLD SWEAT (Cold sweats). On 24-Apr-2021, the patient experienced INJECTION SITE BRUISING (Bruising at injection site). On 25-Apr-2021, the patient experienced LYMPHADENOPATHY (Swollen/tender lymph nodes underarm on the side of the injection site). On an unknown date, the patient experienced CHILLS (Chills). On 25-Apr-2021, COLD SWEAT (Cold sweats), MYALGIA (Sore arm/body ache), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PAIN (pain at injection site) had resolved. On 30-Apr-2021, LYMPHADENOPATHY (Swollen/tender lymph nodes underarm on the side of the injection site) had resolved. On 03-May-2021, INJECTION SITE BRUISING (Bruising at injection site) had resolved. At the time of the report, CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Birth control medication were also included in concomitant products. No treatment medication reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Patient demographics, reporter information, vaccination facility details, medical history, concomitant medication, dose details added. Events updated. On 19-Jul-2021: Follow up received that contains NNI. Dosage regimen information and Vaccination site pain event were added from initial follow up.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Nausea, Vaccination site pain
Clinical narrative: Chills; Swollen/tender lymph nodes underarm on the side of the injection site; Bruising at injection site; Cold sweats; Sore arm/body ache; Fatigue; Nausea; Headache; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (Bruising at injection site), COLD SWEAT (Cold sweats), LYMPHADENOPATHY (Swollen/tender lymph nodes underarm on the side of the injection site), MYALGIA (Sore arm/body ache) and FATIGUE (Fatigue) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypothyroidism and Anxiety depression. Concurrent medical conditions included Bee sting and Penicillin allergy. Concomitant products included BUSPIRONE for Anxiety, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for Depression, LEVOTHYROXINE for Hypothyroidism, MELATONIN for Sleep problem.   On 21-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced MYALGIA (Sore arm/body ache), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PAIN (pain at injection site). On 23-Apr-2021 at 5:00 PM, the patient experienced COLD SWEAT (Cold sweats). On 24-Apr-2021, the patient experienced INJECTION SITE BRUISING (Bruising at injection site). On 25-Apr-2021, the patient experienced LYMPHADENOPATHY (Swollen/tender lymph nodes underarm on the side of the injection site). On an unknown date, the patient experienced CHILLS (Chills). On 25-Apr-2021, COLD SWEAT (Cold sweats), MYALGIA (Sore arm/body ache), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PAIN (pain at injection site) had resolved. On 30-Apr-2021, LYMPHADENOPATHY (Swollen/tender lymph nodes underarm on the side of the injection site) had resolved. On 03-May-2021, INJECTION SITE BRUISING (Bruising at injection site) had resolved. At the time of the report, CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Birth control medication were also included in concomitant products. No treatment medication reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Patient demographics, reporter information, vaccination facility details, medical history, concomitant medication, dose details added. Events updated. On 19-Jul-2021: Follow up received that contains NNI. Dosage regimen information and Vaccination site pain event were added from initial follow up.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Deafness, Hypotension, Magnetic resonance imaging head, Tinnitus
Clinical narrative: hearing loss; Left ear tinnitus; Hypotensive episode; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Hypotensive episode), DEAFNESS (hearing loss) and TINNITUS (Left ear tinnitus) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 011J20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis, Hypersensitivity reaction and Urticaria. Concurrent medical conditions included Allergy to vaccine (Rabies vax(uticaria, anaphylaxis, received EPI)) since 1995 and Allergy to vaccine (Flu shot(lip swelling, cough, dysgeusia)) since 2011. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) for Birth control.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021 at 1:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced HYPOTENSION (Hypotensive episode). On an unknown date, the patient experienced DEAFNESS (hearing loss) and TINNITUS (Left ear tinnitus). At the time of the report, HYPOTENSION (Hypotensive episode), DEAFNESS (hearing loss) and TINNITUS (Left ear tinnitus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Acoustic stimulation tests: abnormal (abnormal) acute left sided sensorineural hearing loss. On 19-Apr-2021, Acoustic stimulation tests: abnormal (abnormal) acute left sided sensorineural hearing loss. On 03-May-2021, Magnetic resonance imaging head: negative (Negative) negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include  dexamethasone injection to left ear and started me on oral predisone and discontinued the diurectic.    Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Non-Significant follow up appended to AER
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Chills, Erythema, Fatigue
Clinical narrative: feeling bad; swelling; bright red; shingles; unable to sleep; aches; pains in his bones; itches like fire; chills; 101.8F; very tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles) and INSOMNIA (unable to sleep) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles), INSOMNIA (unable to sleep), PAIN (aches), BONE PAIN (pains in his bones), PRURITUS (itches like fire), CHILLS (chills), PYREXIA (101.8F) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles), INSOMNIA (unable to sleep), PAIN (aches), BONE PAIN (pains in his bones), PRURITUS (itches like fire), CHILLS (chills), PYREXIA (101.8F) and FATIGUE (very tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, Body temperature: 101.8 (High) 101.8F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Herpes zoster, Insomnia, Pain, Pruritus
Clinical narrative: feeling bad; swelling; bright red; shingles; unable to sleep; aches; pains in his bones; itches like fire; chills; 101.8F; very tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles) and INSOMNIA (unable to sleep) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles), INSOMNIA (unable to sleep), PAIN (aches), BONE PAIN (pains in his bones), PRURITUS (itches like fire), CHILLS (chills), PYREXIA (101.8F) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles), INSOMNIA (unable to sleep), PAIN (aches), BONE PAIN (pains in his bones), PRURITUS (itches like fire), CHILLS (chills), PYREXIA (101.8F) and FATIGUE (very tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, Body temperature: 101.8 (High) 101.8F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Swelling
Clinical narrative: feeling bad; swelling; bright red; shingles; unable to sleep; aches; pains in his bones; itches like fire; chills; 101.8F; very tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles) and INSOMNIA (unable to sleep) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles), INSOMNIA (unable to sleep), PAIN (aches), BONE PAIN (pains in his bones), PRURITUS (itches like fire), CHILLS (chills), PYREXIA (101.8F) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, FEELING ABNORMAL (feeling bad), SWELLING (swelling), ERYTHEMA (bright red), HERPES ZOSTER (shingles), INSOMNIA (unable to sleep), PAIN (aches), BONE PAIN (pains in his bones), PRURITUS (itches like fire), CHILLS (chills), PYREXIA (101.8F) and FATIGUE (very tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, Body temperature: 101.8 (High) 101.8F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Maternal exposure during pregnancy, Pyrexia
Clinical narrative: Mild Fever; Joint pain; Tiredness; Pregant;received both doses of Moderna COVID-19 vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregant;received both doses of Moderna COVID-19 vaccine), PYREXIA (Mild Fever), ARTHRALGIA (Joint pain) and FATIGUE (Tiredness) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was in September 2020 and the estimated date of delivery was 15-Jun-2021. On 05-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregant;received both doses of Moderna COVID-19 vaccine). On 02-Apr-2021, the patient experienced PYREXIA (Mild Fever), ARTHRALGIA (Joint pain) and FATIGUE (Tiredness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 05-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregant;received both doses of Moderna COVID-19 vaccine) had resolved. On 03-Apr-2021, PYREXIA (Mild Fever), ARTHRALGIA (Joint pain) and FATIGUE (Tiredness) had resolved.            No concomitant medication information was provided by the reporter.  No treatment information was provided by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tired; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 032L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: EUFLEXXA (Euflexxa injections) and CORTIZONE [HYDROCORTISONE] (cortizone shot). Concurrent medical conditions included Drug allergy (suprex), Drug allergy (ceclor) and Joint disorder NOS (Improvement with cortizone shot and Euflexxa injections) since 24-Nov-2020. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), HYDROXYZINE EMBONATE (VISTARIL [HYDROXYZINE EMBONATE]), HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), ROSUVASTATIN CALCIUM (CRESTOR) and LORAZEPAM (ATIVAN) for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included benadryl 2 hours before shot.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Vertigo
Clinical narrative: dizzy spells/gets up or sits down too fast experiences dizziness; room feels like it is spinning/thinks it is vertigo; arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), DIZZINESS (dizzy spells/gets up or sits down too fast experiences dizziness) and VERTIGO (room feels like it is spinning/thinks it is vertigo) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN and ALLOPURINOL for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm hurt). On 21-Apr-2021, the patient experienced VERTIGO (room feels like it is spinning/thinks it is vertigo). On 22-Apr-2021, the patient experienced DIZZINESS (dizzy spells/gets up or sits down too fast experiences dizziness). On 21-Apr-2021, PAIN IN EXTREMITY (arm hurt) had resolved. On 28-Apr-2021, VERTIGO (room feels like it is spinning/thinks it is vertigo) had resolved. At the time of the report, DIZZINESS (dizzy spells/gets up or sits down too fast experiences dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Significant follow up appended: the information added were address, email was provided, new event was added, stop date for events was provided.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue
Clinical narrative: This spontaneous case reported by a pharmacist, describes the occurrence of COVID-19 (tested positive for COVID-19) and fatigue (feels tired) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 028A21A) for COVID-19 immunization. No medical history reported. On Mar 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 5, 2021, patient had COVID-19 (tested positive for COVID-19). On an unknown date, patient experienced fatigue (feels tired). At the time of the report, COVID-19 (tested positive for COVID-19) outcome: unknown; and fatigue (feels tired): not resolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment medication. This case linked to MOD-2021-089547 (E2B linked report). Sender's comments: MOD-2021-089547: wife's case.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Like flu symptoms; Muscle pains; Fever; General tiredness; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Like flu symptoms), MYALGIA (Muscle pains), PYREXIA (Fever) and FATIGUE (General tiredness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Like flu symptoms), MYALGIA (Muscle pains), PYREXIA (Fever) and FATIGUE (General tiredness). At the time of the report, INFLUENZA LIKE ILLNESS (Like flu symptoms), MYALGIA (Muscle pains), PYREXIA (Fever) and FATIGUE (General tiredness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events are not applicable.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Mixed Dose Series; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Mixed Dose Series) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Mixed Dose Series). On 23-Apr-2021, PRODUCT DOSE OMISSION ISSUE (Mixed Dose Series) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; Headache; This spontaneous case was reported by a health care professional and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting) and HEADACHE (Headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Urticaria, Angioedema and Pruritus.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting) and HEADACHE (Headache). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment drugs were not provided  Concomitant medicines were not included.  Upon internal review on 04-Aug-2021, the age was corrected to 52 years.   Action taken with mRNA-1273 in response to the event was unknown
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Illness, Induration, Nausea, Pain in extremity
Clinical narrative: Weakness; Feeling sickness; Sore injection arm; Swollen injection arm; Hardness of the arm; Nauseated stomach; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), ILLNESS (Feeling sickness), PAIN IN EXTREMITY (Sore injection arm), PERIPHERAL SWELLING (Swollen injection arm) and INDURATION (Hardness of the arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 018A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included GERD. Concomitant products included ATENOLOL and INSULIN DETEMIR (LEVEMIR) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced ASTHENIA (Weakness), ILLNESS (Feeling sickness), PAIN IN EXTREMITY (Sore injection arm), PERIPHERAL SWELLING (Swollen injection arm), INDURATION (Hardness of the arm) and NAUSEA (Nauseated stomach). On 06-Mar-2021, INDURATION (Hardness of the arm) had resolved. On 08-Mar-2021, ASTHENIA (Weakness), ILLNESS (Feeling sickness), PAIN IN EXTREMITY (Sore injection arm), PERIPHERAL SWELLING (Swollen injection arm) and NAUSEA (Nauseated stomach) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Products known to have been used by the patient, within two weeks prior to the event, included medication for GERD (Gastroesophageal reflux disease). Treatment for the event included naproxen  and acetaminophen.   This case was linked to MOD-2021-071057 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up included medical history of the patient, current condition of the patient, concomitant medication and new event information.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Weakness; Feeling sickness; Sore injection arm; Swollen injection arm; Hardness of the arm; Nauseated stomach; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), ILLNESS (Feeling sickness), PAIN IN EXTREMITY (Sore injection arm), PERIPHERAL SWELLING (Swollen injection arm) and INDURATION (Hardness of the arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 018A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included GERD. Concomitant products included ATENOLOL and INSULIN DETEMIR (LEVEMIR) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced ASTHENIA (Weakness), ILLNESS (Feeling sickness), PAIN IN EXTREMITY (Sore injection arm), PERIPHERAL SWELLING (Swollen injection arm), INDURATION (Hardness of the arm) and NAUSEA (Nauseated stomach). On 06-Mar-2021, INDURATION (Hardness of the arm) had resolved. On 08-Mar-2021, ASTHENIA (Weakness), ILLNESS (Feeling sickness), PAIN IN EXTREMITY (Sore injection arm), PERIPHERAL SWELLING (Swollen injection arm) and NAUSEA (Nauseated stomach) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Products known to have been used by the patient, within two weeks prior to the event, included medication for GERD (Gastroesophageal reflux disease). Treatment for the event included naproxen  and acetaminophen.   This case was linked to MOD-2021-071057 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up included medical history of the patient, current condition of the patient, concomitant medication and new event information.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Pain in extremity, Vaccination site pain
Clinical narrative: headaches; injection site pain; higher than normal blood pressure; pain in arm; This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (headaches), VACCINATION SITE PAIN (injection site pain), HYPERTENSION (higher than normal blood pressure) and PAIN IN EXTREMITY (pain in arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches), VACCINATION SITE PAIN (injection site pain), HYPERTENSION (higher than normal blood pressure) and PAIN IN EXTREMITY (pain in arm). At the time of the report, HEADACHE (headaches), VACCINATION SITE PAIN (injection site pain), HYPERTENSION (higher than normal blood pressure) and PAIN IN EXTREMITY (pain in arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment icepack at night after first vaccine.   This case was linked to MOD-2021-014742 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: body aches; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), HEADACHE (Headache) and FATIGUE (Fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 04L20A) for COVID-19 vaccination.     The patient's past medical history included Thrombocytosis (High blood platelets) since 2010. Concomitant products included HYDROXYUREA for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN (body aches), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, PAIN (body aches), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.            This case was linked to MOD-2021-016528 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Pruritus
Clinical narrative: Itching all over body / back / head; Did not take the second vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching all over body / back / head) and PRODUCT DOSE OMISSION ISSUE (Did not take the second vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included Stomach inflammation. Concomitant products included FAMOTIDINE and RETINOL, TOCOPHEROL (VITAMIN A-E).    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching all over body / back / head) and PRODUCT DOSE OMISSION ISSUE (Did not take the second vaccine). At the time of the report, PRURITUS (Itching all over body / back / head) and PRODUCT DOSE OMISSION ISSUE (Did not take the second vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment products included Steroid.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Pruritus
Clinical narrative: joint pain and intense itching; intense itching; redness; This spontaneous case was reported by an other and describes the occurrence of ARTHRALGIA (joint pain and intense itching), PRURITUS (intense itching) and ERYTHEMA (redness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product OBETICHOLIC ACID (OCALIVA) for Primary biliary cirrhosis.    Concurrent medical conditions included Primary biliary cirrhosis, Hypertension, Perfume sensitivity and Child-Turcotte-Pugh class A. Concomitant products included URSODEOXYCHOLIC ACID for an unknown indication.   On 20-Dec-2019, the patient OBETICHOLIC ACID (OCALIVA) (Oral) dosage was changed to 5 milligram once a day. On 12-Jan-2020, OBETICHOLIC ACID (OCALIVA) (Oral) dosage was changed to 5 milligram once a day. In July 2020, OBETICHOLIC ACID (OCALIVA) (Oral) dosage was changed to dosage form. On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started OBETICHOLIC ACID (OCALIVA) (Oral) 5 milligram once a day. On 25-Mar-2021, the patient experienced ARTHRALGIA (joint pain and intense itching), PRURITUS (intense itching) and ERYTHEMA (redness). At the time of the report, ARTHRALGIA (joint pain and intense itching), PRURITUS (intense itching) and ERYTHEMA (redness) outcome was unknown.            Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Feeling hot, Pain, Pyrexia
Clinical narrative: Feel warm; chills; temperature was 100; felt achy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt achy), FEELING HOT (Feel warm), CHILLS (chills) and PYREXIA (temperature was 100) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 024M20A) for COVID-19 vaccination.     Concomitant products included ATENOLOL from 01-Jul-2000 to an unknown date, LOSARTAN from 01-Jan-2010 to an unknown date, PRAVASTATIN from 01-Jan-2005 to an unknown date, OMEPRAZOLE from 01-Jan-2015 to an unknown date, CALCIUM from 01-Jun-2020 to an unknown date and VITAMIN D NOS from 01-Jun-2020 to an unknown date for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (felt achy), CHILLS (chills) and PYREXIA (temperature was 100). On 10-Mar-2021 at 7:30 PM, the patient experienced FEELING HOT (Feel warm). On 10-Mar-2021, PYREXIA (temperature was 100) had resolved. On 11-Mar-2021, PAIN (felt achy), FEELING HOT (Feel warm) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 100.         The patient took two Tylenol extra strength as treatment medication   This case was linked to MOD-2021-031364 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis
Clinical narrative: Felt dizzy and lightheaded; Started sweating intensely; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy and lightheaded) and HYPERHIDROSIS (Started sweating intensely) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Felt dizzy and lightheaded) and HYPERHIDROSIS (Started sweating intensely). At the time of the report, DIZZINESS (Felt dizzy and lightheaded) and HYPERHIDROSIS (Started sweating intensely) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No  treatment details was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: arm soreness; This spontaneous case was reported by an other and describes the occurrence of ARTHRALGIA (arm soreness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 003A21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for Cholesterol, LUBIPROSTONE (AMITIZA) for Constipation, VITAMIN D3 and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (arm soreness). At the time of the report, ARTHRALGIA (arm soreness) had resolved.            Treatment medication not provided.   This case was linked to MOD-2021-042985 (Linked Report).; Sender's Comments:  MOD-2021-042985:2nd dose AEs